The groundbreaking therapy of the medication represents a major development in the care of diabetes mellitus type 2. Distinct from existing medications, tirzepatide targets dual pathways – glucagon-like peptide-1 https://tirzepatide-peptide061117.targetblogs.com/42323483/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment